Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site revision changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T15:25:37.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide notice about NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” appears above the page content.
    Difference
    1%
    Check dated 2026-10-24T18:14:22.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T20:23:02.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T20:35:54.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    403 Forbidden page is shown in place of the study record, removing access to the study details and related sections. This indicates the page is now restricted to access.
    Difference
    17%
    Check dated 2026-09-19T20:29:45.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor maintenance update. No study details, eligibility criteria, or other user-facing content were modified.
    Difference
    0.1%
    Check dated 2026-08-29T20:06:09.000Z thumbnail image

Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.